🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
18,156
Companies
1,062
Drugs tracked
3,385

Quick answer

NovaPharmaNews tracks 18,156 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

88 results for “rituximab” Clear

  1. penpulimab, lenalidomide, Rituximab, Gemcitabine, Oxaliplatin

    First Tracks Biotherapeutics

    Lymphoma, Large B-Cell, Diffuse

    phase 2 small molecule active

    1 trial

  2. rituximab

    United Therapeutics Europe Ltd

    Lymphoma

    phase 2 mab completed

    1 trial

  3. rituximab

    Ultragenyx UK Limited

    Purpura, Thrombocytopenic, Idiopathic

    phase 2 small molecule completed

    1 trial

  4. rituximab /Dexamethasone/cyclophosphamide

    First Tracks Biotherapeutics

    Treatment

    phase 2 small molecule active

    1 trial

  5. 20 mg/kg TRU-016 + Rituximab

    Aptevo Therapeutics

    Chronic Lymphocytic Leukemia

    phase 1 mab terminated

    1 trial

  6. A Phase 1b, Multicenter, Open-label Study of Acalabrutinib in Combination with Bendamustine and Rituximab (BR) or Venetoclax and Rituximab (VR) in Subjects with Mantle Cell Lymphoma

    Pharma Mar S.A.

    Mantle Cell Lymphoma

    phase 1 other active

    1 trial

  7. A Study Evaluating the Safety, Efficacy and Pharmacokinetics of Venetoclax in Combination With Polatuzumab Vedotin Plus Rituximab (R) and Cyclophosphamide, Doxorubicin, Prednisone (CHP) in Participants With Untreated BCL-2 Immunohistochemistry (IHC)-Positive Diffuse Large B-Cell Lymphoma (DLBCL)

    Roche Registration Limited

    Diffuse large B-cell lymphoma (DLBCL), Grade 3B follicular lymphoma, High grade B-cell lymphoma (HGBL), Epstein-Barr virus−positive DLBCL

    phase 1 other active

    1 trial

  8. Loncastuximab tesirine and rituximab (Lonca-R)

    ADC Therapeutics SA

    Central Nervous System Lymphoma

    phase 1 small molecule active

    1 trial

  9. Rituximab

    China SXT Pharmaceuticals

    Head and Neck Squamous Carcinoma

    phase 1 small molecule completed

    1 trial

  10. Rituximab

    First Tracks Biotherapeutics

    Diffuse Large B-cell Lymphoma Recurrent

    phase 1 small molecule active

    1 trial

  11. METHOTREXATE , MYCOPHENOLIC ACID , AZATHIOPRINE , Tavneos 10 mg hard capsules, CYCLOPHOSPHAMIDE , -, RITUXIMAB, Placebo for AMG 569

    Amgen Technology (Ireland) UC

    Antineutrophil cytoplasmic antibody-associated vasculitis (AAV)

    approved small molecule active

    1 trial

  12. Rituximab

    First Tracks Biotherapeutics

    Hemophagocytic Lymphohistiocytosis

    approved small molecule active

    1 trial

  13. rituximab combined with corticosteroids

    First Tracks Biotherapeutics

    Primary Membranous Nephropathy

    approved small molecule active

    1 trial

  14. Rituximab

    China SXT Pharmaceuticals

    Peripheral T-Cell Lymphoma, Not Otherwise Specified

    small molecule active

    1 trial

  15. Rituximab

    China SXT Pharmaceuticals

    Immune Thrombocytopenic Purpura

    small molecule completed

    1 trial

  16. Rituximab, Methotrexate, and Thiotepa (R-MT) Induction Followed by Etoposide and Cytarabine (EA) Consolidation

    First Tracks Biotherapeutics

    Primary Central Nervous System Lymphoma (PCNSL)

    small molecule active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 18,156 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources